These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 25896110)

  • 1. Adverse effects of low-dose systemic cyclosporine therapy in high-risk penetrating keratoplasty.
    Lee JJ; Kim MK; Wee WR
    Graefes Arch Clin Exp Ophthalmol; 2015 Jul; 253(7):1111-9. PubMed ID: 25896110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of postoperative immunosuppression after keratoplasty in herpetic keratitis.
    Maier AK; Ozlügedik S; Rottler J; Heussen FM; Klamann MK; Huber KK; Joussen AM; Winterhalter S
    Cornea; 2011 Dec; 30(12):1398-405. PubMed ID: 21996945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppression with cyclosporine A and mycophenolate mofetil after penetrating high-risk keratoplasty: a retrospective study.
    Birnbaum F; Böhringer D; Sokolovska Y; Sundmacher R; Reinhard T
    Transplantation; 2005 Apr; 79(8):964-8. PubMed ID: 15849551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse events associated with the use of cyclosporine in patients with inflammatory bowel disease.
    Sternthal MB; Murphy SJ; George J; Kornbluth A; Lichtiger S; Present DH
    Am J Gastroenterol; 2008 Apr; 103(4):937-43. PubMed ID: 18177449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of low-dose and long-term oral acyclovir therapy after penetrating keratoplasty for herpes simplex heratitis.
    Akova YA; Onat M; Duman S
    Ocul Immunol Inflamm; 1999 Mar; 7(1):51-60. PubMed ID: 10410875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mycophenolate mofetil after penetrating high risk keratoplasty. A pilot study].
    Reinhard T; Reis A; Kutkuhn B; Voiculescu A; Sundmacher R
    Klin Monbl Augenheilkd; 1999 Sep; 215(3):201-2. PubMed ID: 10528287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Postoperative therapy after penetrating keratoplasty in herpes simplex keratitis].
    Süveges I; Füst Á; Imre L
    Orv Hetil; 2013 Dec; 154(52):2065-70. PubMed ID: 24374582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the Rapamune Maintenance Regimen Study.
    Oberbauer R; Kreis H; Johnson RW; Mota A; Claesson K; Ruiz JC; Wilczek H; Jamieson N; Henriques AC; Paczek L; Chapman J; Burke JT;
    Transplantation; 2003 Jul; 76(2):364-70. PubMed ID: 12883194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term outcome of topical cyclosporine treatment following penetrating keratoplasty].
    Inoue K; Amano S; Kimura C; Sato T; Fujita N; Kagaya F; Kaji Y; Oshika T; Tsuru T; Araie M
    Nippon Ganka Gakkai Zasshi; 1999 Apr; 103(4):306-10. PubMed ID: 10339976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats.
    Bourges JL; Lallemand F; Agla E; Besseghir K; Dumont JM; BenEzra D; Gurny R; Behar-Cohen F
    Mol Vis; 2006 Dec; 12():1461-6. PubMed ID: 17167400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of systemic tacrolimus in high-risk penetrating keratoplasty after graft failure with systemic cyclosporine.
    Yamazoe K; Yamazoe K; Yamaguchi T; Omoto M; Shimazaki J
    Cornea; 2014 Nov; 33(11):1157-63. PubMed ID: 25255133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel cyclosporine a drug-delivery system for prevention of human corneal rejection after high-risk keratoplasty: a clinical study.
    Shi W; Chen M; Xie L; Liu M; Gao H; Wang T; Wu X; Zhao J
    Ophthalmology; 2013 Apr; 120(4):695-702. PubMed ID: 23246118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term comparison of full-bed deep lamellar keratoplasty with penetrating keratoplasty in treating corneal leucoma caused by herpes simplex keratitis.
    Wu SQ; Zhou P; Zhang B; Qiu WY; Yao YF
    Am J Ophthalmol; 2012 Feb; 153(2):291-299.e2. PubMed ID: 21996306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of high risk corneal graft rejection using cyclosporine A (CsA) incorporated into a collagen matrix.
    Mahlberg K; Uusitalo RJ; Oksala O
    Ocul Immunol Inflamm; 1997 Jun; 5(2):101-10. PubMed ID: 9234374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic cyclosporin A in high risk penetrating keratoplasties: a case-control study.
    Poon AC; Forbes JE; Dart JK; Subramaniam S; Bunce C; Madison P; Ficker LA; Tuft SJ; Gartry DS; Buckley RJ
    Br J Ophthalmol; 2001 Dec; 85(12):1464-9. PubMed ID: 11734522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine a drug-delivery system for high-risk penetrating keratoplasty: Stabilizing the intraocular immune microenvironment.
    Zhang T; Li Z; Liu T; Li S; Gao H; Wei C; Shi W
    PLoS One; 2018; 13(5):e0196571. PubMed ID: 29734357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical cyclosporine in pediatric keratoplasty.
    Cosar CB; Laibson PR; Cohen EJ; Rapuano CJ
    Eye Contact Lens; 2003 Apr; 29(2):103-7. PubMed ID: 12695714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early steroid withdrawal after liver transplantation: the Canadian tacrolimus versus microemulsion cyclosporin A trial: 1-year follow-up.
    Greig P; Lilly L; Scudamore C; Erb S; Yoshida E; Kneteman N; Bain V; Ghent C; Marotta P; Grant D; Wall W; Tchervenkov J; Barkun J; Roy A; Marleau D; McAlister V; Peltekian K
    Liver Transpl; 2003 Jun; 9(6):587-95. PubMed ID: 12783400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of cyclosporin A absorption for effective immunomodulatory therapy after high-risk keratoplasty].
    Bailly N; Dunewa I; Schlattmann P; Rieck PW
    Ophthalmologe; 2008 May; 105(5):457-62. PubMed ID: 18299847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic cyclosporine in high-risk keratoplasty. Short- versus long-term therapy.
    Hill JC
    Ophthalmology; 1994 Jan; 101(1):128-33. PubMed ID: 8302545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.